Global Clinical Decision Support System (CDSS) Market to Grow Over $1,500 Million by 2022 - Acumen Research and Consulting

Author: Acumen Research and Consulting

According to a new report published by Acumen Research and Consulting titled Clinical Decision Support System (CDSS) Market (Solutions: Integrated CDSS Solutions, Standalone CDSS Solutions; Application: Clinical Guidelines, Drug Dosing Support, Clinical Reminders, Drug Allergy Alerts, Drug-Drug Interactions, Others; Model: Knowledge-based CDSS Solution, Non-Knowledge-based CDSS Solution; Mode of Delivery: On-premise, Web Based, Cloud Based; Component: Hardware, Software, Service; Entity Capacity: Less than 100 Beds, 100–199 Beds, 200–299 Beds, 300–399 Beds, 400–499 Beds, More than 500 Beds) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2012-2022, the global market for clinical decision support system (CDSS) is projected to grow at a significant rate and reach the market value of over $1,500 Million by 2022. Growing need for remote patient monitoring services has encouraged market players to invest in advanced healthcare information systems, thus driving the growth of CDSS market. Also, increasing support from government organizations is supporting the growth of this market. Increasing popularity and preference for CDSS in healthcare facilities is the key trend witnessed in global CDSS market currently. Despite these factors, data security issues and privacy concerns, since the patient’s personal information is stored in healthcare information systems, are the major factors restricting the growth of this market. High capital expenditure, regular maintenance, and lack of healthcare infrastructure in developing economies are other factors limiting the growth of CDSS market to some extent.

Review Sample Pages -

Clinical support system is an application that helps healthcare providers to make effective clinical decisions. It is an adaptation of decision support systems that are commonly used in managing business processes. These systems help in implementation of clinical guidelines at the point of care. CDSS uses patient’s information to offer recommendations to healthcare providers on the treatment to be provided to the patient and delivers enhanced clinical outcome. The major applications of clinical decision support system include drug dosing support, drug-drug interactions, drug allergy alerts, clinical guidelines and clinical reminders. The global clinical decision support systems market is expected to display significant growth of over 21% during the period from 2016 to 2022.


The global clinical decision support systems market is segmented based on solutions, applications, model, mode of delivery, component, healthcare entity capacity, and geography. Among different geographies analyzed in the report, North America led the global market accounting for the share of more than 50% in 2015. The growth of CDSS solutions in North America is mainly spurred by the established healthcare infrastructure, rise in geriatric population, increased spending on healthcare, and growing prevalence of chronic illnesses. As per a report from ADA (American Diabetes Association), around 25.8 million Americans suffered from diabetes in 2010 and the number increased to 29.1 million in 2012. World Health Organization predicted that approximately 324,000 new cases of lung cancer were identified in 2012 in North America and the number is expected to grow to 541,000 by 2030. This has creased significant impact on the growth of CDSS market in North America owing to the growing demand of medicines for disease management. North America is expected to maintain its dominant share in the CDSS market throughout the forecast period. Asia-Pacific is expected to be the fastest growing market for the deployment of CDSS solutions. Growing demand for remote patient monitoring and increased life expectancy are likely to increase the investments in healthcare IT solutions in Asia-Pacific region, and eventually driving the growth of CDSS market.

Browse complete report at:

Integrated and standalone solution are the two major types of CDSS solutions offered. Amongst these, integrated CDSS solution is the most popular type, and accounted for over 70% share in 2015 and is expected to grow at a CAGR of over 22% during the forecast period from 2016 to 2022. Some of the major applications of CDSS include drug allergy alerts, drug-drug interactions, clinical reminders, clinical guidelines, drug dosing support, and others. CDSS solutions are most important in offering information on allergy against any specific drug to the patient and assist healthcare service providers in treating the illness in more effective way. Drug allergy alert segment accounted for the largest share in 2015 in the global CDSS market and is expected to grow at a CAGR of around 22% during the estimated period.

Among the player operating in the global CDSS market, some profiled in the report include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions Inc., IBM Corporation, Relx Group Plc, Mckesson Corporation, General Electric Company, Siemens AG, Meditech, and Zynx Health Incorporated among others.  Partnership expansion, strategic relationships for technology sharing and development, and acquisitions are some major strategies followed by leading players in this market to sustain market competition. 

Inquiry Before Buying:
The report is readily available and can be dispatched immediately after payment confirmation.
Would like to place an order or any question, please feel free to contact: